- Home
- PAYO vs INSP Comparison
PAYO vs INSP Comparison
Compare PAYO & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAYO | INSP |
|---|---|---|
| Founded | 2005 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | PAYO | INSP |
|---|---|---|
| Price | $6.14 | $81.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 16 |
| Target Price | $8.93 | ★ $133.07 |
| AVG Volume (30 Days) | ★ 3.4M | 1.2M |
| Earning Date | 02-26-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.77 |
| EPS | 0.18 | ★ 1.48 |
| Revenue | ★ $1,039,820,000.00 | $882,622,000.00 |
| Revenue This Year | $10.67 | $15.15 |
| Revenue Next Year | $6.28 | $10.98 |
| P/E Ratio | ★ $33.76 | $53.79 |
| Revenue Growth | 10.58 | ★ 16.81 |
| 52 Week Low | $4.92 | $70.77 |
| 52 Week High | $11.19 | $203.12 |
Technical Indicators
Market Signals| Indicator | PAYO | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 67.47 | 33.81 |
| Support Level | $5.21 | $77.75 |
| Resistance Level | $5.53 | $97.52 |
| Average True Range (ATR) | 0.21 | 5.73 |
| MACD | 0.09 | -1.20 |
| Stochastic Oscillator | 85.66 | 12.21 |
Price Performance
Historical ComparisonAbout PAYO Payoneer Global Inc.
Payoneer Global Inc is a financial technology company purpose-built to enable the world's small and medium-sized businesses (SMB(s)) to grow and operate their businesses around the world by reliably and securely connecting them to the digital economy. The company started to empower commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.